Your search returned 1978 results.

Results
	1921.	Residual Inflammatory Risk on Treatment With PCSK9 Inhibition and Statin Therapy. [electronic resource] by Pradhan, Aruna D Aday, Aaron W Rose, Lynda M Ridker, Paul M Producer: 20190919 In: Circulation vol. 138 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1922.	Burden of familial heterozygous hypercholesterolemia in Uzbekistan: Time is muscle. [electronic resource] by Shek, Aleksandr Alieva, Rano Kurbanov, Ravshanbek Hoshimov, Shavkat Nizamov, Ulugbek Abdullaeva, Guzal Nagay, Aleksandr Producer: 20191101 In: Atherosclerosis vol. 277 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1923.	PCSK9 levels in abdominally obese men: association with cardiometabolic risk profile and effects of a one-year lifestyle modification program. [electronic resource] by Arsenault, Benoit J Pelletier-Beaumont, Emilie Alméras, Natalie Tremblay, Angelo Poirier, Paul Bergeron, Jean Després, Jean-Pierre Producer: 20150702 In: Atherosclerosis vol. 236 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1924.	Impact of Age on the Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia. [electronic resource] by Ginsberg, Henry N Tuomilehto, Jaakko Hovingh, G Kees Cariou, Bertrand Santos, Raul D Brown, Alan S Sanganalmath, Santosh K Koren, Andrew Thompson, Desmond Raal, Frederick J Producer: 20190722 In: Cardiovascular drugs and therapy vol. 33 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1925.	Absence of ANGPTL4 in adipose tissue improves glucose tolerance and attenuates atherogenesis. [electronic resource] by Aryal, Binod Singh, Abhishek K Zhang, Xinbo Varela, Luis Rotllan, Noemi Goedeke, Leigh Chaube, Balkrishna Camporez, Joao-Paulo Vatner, Daniel F Horvath, Tamas L Shulman, Gerald I Suárez, Yajaira Fernández-Hernando, Carlos Producer: 20191021 In: JCI insight vol. 3 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1926.	PCSK9 Induces CD36 Degradation and Affects Long-Chain Fatty Acid Uptake and Triglyceride Metabolism in Adipocytes and in Mouse Liver. [electronic resource] by Demers, Annie Samami, Samaneh Lauzier, Benjamin Des Rosiers, Christine Ngo Sock, Emilienne Tudor Ong, Huy Mayer, Gaetan Producer: 20160317 In: Arteriosclerosis, thrombosis, and vascular biology vol. 35 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1927.	Efficacy and safety of lipid lowering by alirocumab in chronic kidney disease. [electronic resource] by Toth, Peter P Dwyer, Jamie P Cannon, Christopher P Colhoun, Helen M Rader, Daniel J Upadhyay, Ashish Louie, Michael J Koren, Andrew Letierce, Alexia Mandel, Jonas Banach, Maciej Producer: 20181217 In: Kidney international vol. 93 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1928.	LDL-cholesterol target achievement in patients with heterozygous familial hypercholesterolemia at Groote Schuur Hospital: Minority at target despite large reductions in LDL-C. [electronic resource] by van Delden, Xander M Huijgen, Roeland Wolmarans, Karen H Brice, Brigitte C Barron, Jennifer K Blom, Dirk J Marais, A David Producer: 20191101 In: Atherosclerosis vol. 277 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1929.	Reduced VLDL clearance in Apoe(-/-)Npc1(-/-) mice is associated with increased Pcsk9 and Idol expression and decreased hepatic LDL-receptor levels. [electronic resource] by Ishibashi, Minako Masson, David Westerterp, Marit Wang, Nan Sayers, Scott Li, Rong Welch, Carrie L Tall, Alan R Producer: 20110214 In: Journal of lipid research vol. 51 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1930.	Report of the American College of Cardiology (ACC) Scientific Sessions 2015, San Diego. [electronic resource] by Murohara, Toyoaki Producer: 20160301 In: Circulation journal : official journal of the Japanese Circulation Society vol. 79 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1931.	Rationale and design of the Further cardiovascular OUtcomes Research with PCSK9 Inhibition in subjects with Elevated Risk trial. [electronic resource] by Sabatine, Marc S Giugliano, Robert P Keech, Anthony Honarpour, Narimon Wang, Huei Liu, Thomas Wasserman, Scott M Scott, Robert Sever, Peter S Pedersen, Terje R Producer: 20160712 In: American heart journal vol. 173 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1932.	Comparative Effects of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition and Statins on Postprandial Triglyceride-Rich Lipoprotein Metabolism. [electronic resource] by Chan, Dick C Watts, Gerald F Somaratne, Ransi Wasserman, Scott M Scott, Rob Barrett, P Hugh R Producer: 20190715 In: Arteriosclerosis, thrombosis, and vascular biology vol. 38 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1933.	Endothelin Receptor Antagonism Improves Lipid Profiles and Lowers PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) in Patients With Chronic Kidney Disease. [electronic resource] by Farrah, Tariq E Anand, Atul Gallacher, Peter J Kimmitt, Robert Carter, Edwin Dear, James W Mills, Nicholas L Webb, David J Dhaun, Neeraj Producer: 20191118 In: Hypertension (Dallas, Tex. : 1979) vol. 74 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1934.	Inhibition of PCSK9 transcription by berberine involves down-regulation of hepatic HNF1α protein expression through the ubiquitin-proteasome degradation pathway. [electronic resource] by Dong, Bin Li, Hai Singh, Amar Bahadur Cao, Aiqin Liu, Jingwen Producer: 20150508 In: The Journal of biological chemistry vol. 290 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1935.	Clinical experience of scoring criteria for Familial Hypercholesterolaemia (FH) genetic testing in Wales. [electronic resource] by Haralambos, K Whatley, S D Edwards, R Gingell, R Townsend, D Ashfield-Watt, P Lansberg, P Datta, D B N McDowell, I F W Producer: 20160104 In: Atherosclerosis vol. 240 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1936.	Ezetimibe increases intestinal expression of the LDL receptor gene in dyslipidaemic men with insulin resistance. [electronic resource] by Drouin-Chartier, Jean-Philippe Tremblay, André J Lemelin, Valéry Lépine, Marie-Claude Lamarche, Benoît Couture, Patrick Producer: 20171107 In: Diabetes, obesity & metabolism vol. 18 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1937.	Proprotein convertase subtilisin/kexin type 9 inhibition: a new therapeutic mechanism for reducing cardiovascular disease risk. [electronic resource] by Bergeron, Nathalie Phan, Binh An P Ding, Yunchen Fong, Aleyna Krauss, Ronald M Producer: 20160202 In: Circulation vol. 132 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1938.	Treatment patterns and patient characteristics among early initiators of PCSK9 inhibitors. [electronic resource] by Hines, Dionne M Rane, Pallavi Patel, Jeetvan Harrison, David J Wade, Rolin L Producer: 20190128 In: Vascular health and risk management vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1939.	Clinical Benefit of Evolocumab by Severity and Extent of Coronary Artery Disease: Analysis From FOURIER. [electronic resource] by Sabatine, Marc S De Ferrari, Gaetano M Giugliano, Robert P Huber, Kurt Lewis, Basil S Ferreira, Jorge Kuder, Julia F Murphy, Sabina A Wiviott, Stephen D Kurtz, Christopher E Honarpour, Narimon Keech, Anthony C Sever, Peter S Pedersen, Terje R Producer: 20190916 In: Circulation vol. 138 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1940.	Balanced Dysfunction in the Healthcare Ecosystem Harms Patients. [electronic resource] by Califf, Robert M Producer: 20200629 In: Circulation vol. 140 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

First
Previous
88
89
90
91
92
93
94
95
96
97
98
99
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 1978 results.